n(6)-carboxymethyllysine has been researched along with beta-glucono-1,5-lactone in 1 studies
| Studies (n(6)-carboxymethyllysine) | Trials (n(6)-carboxymethyllysine) | Recent Studies (post-2010) (n(6)-carboxymethyllysine) | Studies (beta-glucono-1,5-lactone) | Trials (beta-glucono-1,5-lactone) | Recent Studies (post-2010) (beta-glucono-1,5-lactone) |
|---|---|---|---|---|---|
| 803 | 44 | 365 | 241 | 3 | 110 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akileshwari, C; Muthenna, P; Reddy, GB | 1 |
1 other study(ies) available for n(6)-carboxymethyllysine and beta-glucono-1,5-lactone
| Article | Year |
|---|---|
Ellagic acid, a new antiglycating agent: its inhibition of Nϵ-(carboxymethyl)lysine.
Topics: Animals; Crystallins; Diabetes Complications; Ellagic Acid; Gluconates; Glycated Hemoglobin; Glycation End Products, Advanced; Humans; Lactones; Lens, Crystalline; Lysine; Male; Muramidase; Organ Culture Techniques; Rats; Rats, Wistar; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2012 |